Literature DB >> 19737142

Chronic antigenic stimuli as a possible explanation for the immunodepression caused by liver cirrhosis.

M Márquez1, C Fernández-Gutiérrez, M Montes-de-Oca, M J Blanco, F Brun, C Rodríguez-Ramos, J A Girón-González.   

Abstract

The objectives of this work were the analysis of the functional characteristics of circulating monocytes and T lymphocytes in patients with liver cirrhosis, and evaluation of the relationship with an increased exposure to antigens due to bacterial translocation. Forty patients with liver cirrhosis (20 with compensated cirrhosis and 20 with ascitic decompensation) and 20 healthy control subjects were studied. Bacterial translocation was evaluated by serum levels of lipopolysaccharide binding protein (LBP). Macrophage activation was studied by CD40 antigen expression. T lymphocytes were analysed for activation (CD25(+), CD122(+)), effector function (CD8(+)CD45RO(+)CD57(+)), apoptosis (CD95(+)) and regulatory abilities, either by analysis of the membrane expression of co-stimulatory molecules CD80, CD86 and CD28, or by quantification of regulatory T cells CD4(+)CD25(high)forkhead box P3 (FoxP3). The percentage of activated monocytes and T lymphocytes in patients was increased significantly. The proportions of effector senescent cells and of those near to apoptosis were also significantly higher. With respect to these proportions, there were no significant differences between patients in function of the presence or absence of decompensation or in function of the increased or normal values of LBP. Conversely, those patients with elevated levels of LBP presented a significantly higher frequency of regulatory T cells than those with normal levels. In conclusion, patients with liver cirrhosis showed an intensive activation state with a higher percentage of cells committed to activation-induced death, even in non-advanced stages. It is possible that bacterial permeability and endotoxaemia contribute to the expansion of those lymphocyte populations implicated in the prevention of a more severe antigen-induced immunopathology.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19737142      PMCID: PMC2768811          DOI: 10.1111/j.1365-2249.2009.04005.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  48 in total

1.  Bacterial translocation in cirrhotic rats stimulates eNOS-derived NO production and impairs mesenteric vascular contractility.

Authors:  R Wiest; S Das; G Cadelina; G Garcia-Tsao; S Milstien; R J Groszmann
Journal:  J Clin Invest       Date:  1999-11       Impact factor: 14.808

2.  CD4+CD25+ regulatory T cells down-regulate co-stimulatory molecules on antigen-presenting cells.

Authors:  L Cederbom; H Hall; F Ivars
Journal:  Eur J Immunol       Date:  2000-06       Impact factor: 5.532

Review 3.  Innate immunity.

Authors:  R Medzhitov; C Janeway
Journal:  N Engl J Med       Date:  2000-08-03       Impact factor: 91.245

Review 4.  The two-signal model of T-cell activation after 30 years.

Authors:  Alain Bernard; Laurence Lamy And; Isabelle Alberti
Journal:  Transplantation       Date:  2002-01-15       Impact factor: 4.939

5.  CD4+CD25+ regulatory T cells control Leishmania major persistence and immunity.

Authors:  Yasmine Belkaid; Ciriaco A Piccirillo; Susana Mendez; Ethan M Shevach; David L Sacks
Journal:  Nature       Date:  2002-12-05       Impact factor: 49.962

Review 6.  Increased expression of NK cell markers on T lymphocytes in aging and chronic activation of the immune system reflects the accumulation of effector/senescent T cells.

Authors:  R Tarazona; O DelaRosa; C Alonso; B Ostos; J Espejo; J Peña; R Solana
Journal:  Mech Ageing Dev       Date:  2000-12-20       Impact factor: 5.432

Review 7.  The B7 family of ligands and its receptors: new pathways for costimulation and inhibition of immune responses.

Authors:  Beatriz M Carreno; Mary Collins
Journal:  Annu Rev Immunol       Date:  2001-10-04       Impact factor: 28.527

Review 8.  A model to predict survival in patients with end-stage liver disease.

Authors:  P S Kamath; R H Wiesner; M Malinchoc; W Kremers; T M Therneau; C L Kosberg; G D'Amico; E R Dickson; W R Kim
Journal:  Hepatology       Date:  2001-02       Impact factor: 17.425

Review 9.  Sonography of diffuse liver disease.

Authors:  Hisham Tchelepi; Philip W Ralls; Randall Radin; Edward Grant
Journal:  J Ultrasound Med       Date:  2002-09       Impact factor: 2.153

10.  Serum and ascitic fluid bacterial DNA: a new independent prognostic factor in noninfected patients with cirrhosis.

Authors:  Pedro Zapater; Rubén Francés; José M González-Navajas; Maria A de la Hoz; Rocío Moreu; Sonia Pascual; David Monfort; Silvia Montoliu; Carmen Vila; Amparo Escudero; Xavier Torras; Isabel Cirera; Lucía Llanos; Carlos Guarner-Argente; José M Palazón; Fernando Carnicer; Pablo Bellot; Carlos Guarner; Ramón Planas; Ricard Solá; Miguel A Serra; Carlos Muñoz; Miguel Pérez-Mateo; José Such
Journal:  Hepatology       Date:  2008-12       Impact factor: 17.425

View more
  23 in total

Review 1.  Novel insights in preventing Gram-negative bacterial infection in cirrhotic patients: review on the effects of GM-CSF in maintaining homeostasis of the immune system.

Authors:  Dong Xu; Manzhi Zhao; Yuhu Song; Jianxin Song; Yuancheng Huang; Junshuai Wang
Journal:  Hepatol Int       Date:  2014-11-21       Impact factor: 6.047

2.  HLA-DP polymorphisms affect the outcomes of chronic hepatitis B virus infections, possibly through interacting with viral mutations.

Authors:  Qi Zhang; Jianhua Yin; Yuwei Zhang; Yang Deng; Xiaowei Ji; Yan Du; Rui Pu; Yifang Han; Jun Zhao; Xue Han; Hongwei Zhang; Guangwen Cao
Journal:  J Virol       Date:  2013-09-04       Impact factor: 5.103

3.  Vigorous, but differential mononuclear cell response of cirrhotic patients to bacterial ligands.

Authors:  Varenka J Barbero-Becerra; María Concepción Gutiérrez-Ruiz; Carmen Maldonado-Bernal; Félix I Téllez-Avila; Roberto Alfaro-Lara; Florencia Vargas-Vorácková
Journal:  World J Gastroenterol       Date:  2011-03-14       Impact factor: 5.742

Review 4.  Leaky gut and the liver: a role for bacterial translocation in nonalcoholic steatohepatitis.

Authors:  Yaron Ilan
Journal:  World J Gastroenterol       Date:  2012-06-07       Impact factor: 5.742

Review 5.  Liver cirrhosis and immune dysfunction.

Authors:  Elda Hasa; Phillipp Hartmann; Bernd Schnabl
Journal:  Int Immunol       Date:  2022-09-06       Impact factor: 5.071

Review 6.  Gut epithelial barrier dysfunction in human immunodeficiency virus-hepatitis C virus coinfected patients: Influence on innate and acquired immunity.

Authors:  Mercedes Márquez; Clotilde Fernández Gutiérrez del Álamo; José Antonio Girón-González
Journal:  World J Gastroenterol       Date:  2016-01-28       Impact factor: 5.742

Review 7.  Risk factors and outcome of bacterial infections in cirrhosis.

Authors:  Tony Bruns; Henning W Zimmermann; Andreas Stallmach
Journal:  World J Gastroenterol       Date:  2014-03-14       Impact factor: 5.742

Review 8.  Immune dysfunction in cirrhosis.

Authors:  Nora Sipeki; Peter Antal-Szalmas; Peter L Lakatos; Maria Papp
Journal:  World J Gastroenterol       Date:  2014-03-14       Impact factor: 5.742

9.  Prevalence of high-risk human papilloma virus among women with hepatitis C virus before liver transplantation.

Authors:  P A Tarallo; J Smolowitz; D Carriero; J Tarallo; A Siegel; H Jia; J C Emond
Journal:  Transpl Infect Dis       Date:  2013-05-06       Impact factor: 2.228

10.  Attenuated antigen-specific T cell responses in cirrhosis are accompanied by elevated serum interleukin-10 levels and down-regulation of HLA-DR on monocytes.

Authors:  Jack Peter; Oliver Frey; Andreas Stallmach; Tony Bruns
Journal:  BMC Gastroenterol       Date:  2013-02-27       Impact factor: 3.067

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.